Obeticholic Acid in Pediatric Subjects With Biliary Atresia
Clinical trial NCT05321524 · TERMINATED
Trial details
- NCT number
- NCT05321524
- Sponsor
- Intercept Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2023-03-09
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.